By Dr. Ravi Kiran Bobba
MD (USA)
American Board Medical Oncology
American Board Hematology
Modern endometrial cancer treatment is evolving rapidly. Today, doctors are moving beyond traditional surgery and using advanced molecular testing, minimally invasive surgery, and precision-guided cancer care to improve treatment outcomes while reducing complications.
At Ravi’s American Cancer Care in Vijayawada, advanced gynecologic oncology approaches such as Sentinel Lymph Node Biopsy, fluorescence-guided surgery, and molecular testing are helping personalize uterine cancer treatment for selected patients.
For many women diagnosed with endometrial cancer (uterine cancer), hysterectomy — surgery to remove the uterus — remains one of the most important treatments.
However, modern cancer care has shown that removing the uterus alone may not always tell the full story.
In some cases, cancer cells may spread to nearby lymph nodes at a microscopic level, remaining undetectable on routine imaging studies despite appearing confined to the uterus.
This is why modern endometrial cancer surgery is increasingly focused not only on removing the tumor, but also on understanding the biological behavior of the cancer.
Yes, in some cases it can.
Nearby pelvic lymph nodes are often the first place where endometrial cancer may spread microscopically.
Traditionally, surgeons removed multiple lymph nodes to check for cancer spread. While effective, extensive lymph node removal could sometimes lead to complications such as:
Modern gynecologic oncology is now moving toward smarter and more precise cancer surgery.
Sentinel Lymph Node Biopsy is one of the most important advancements in modern endometrial cancer surgery.
The sentinel lymph node is the first lymph node that cancer cells are likely to reach if the disease begins to spread through the lymphatic system.
Instead of removing many lymph nodes unnecessarily, surgeons can now identify and evaluate only the most important first lymph nodes.
If these nodes are free of cancer, many patients may avoid extensive lymph node removal.
This approach enhances the accuracy of cancer staging and may lower the risk of surgery-related complications.
At Ravi’s American Cancer Care, advanced fluorescence-guided surgery using SPY-PHI technology integrated with the Stryker 1788 platform helps surgeons visualize lymphatic pathways in real time during minimally invasive gynecologic oncology procedures.
A special fluorescent dye is used during surgery to identify sentinel lymph nodes accurately.
This advanced imaging technology helps support:
Modern cancer surgery is no longer simply about removing more tissue — it is about removing the right tissue with greater precision.
As specialists often say:
“Modern cancer care increasingly focuses on precision and effectiveness rather than more extensive surgical procedures.”
Next Generation Sequencing (NGS) is an advanced molecular testing method used to study the genetic behavior of cancer cells.
Traditionally, cancer treatment decisions were based mainly on:
Today, doctors also study the molecular profile of the tumor.
This helps specialists understand:
In simple language, NGS helps doctors understand the “personality” of the cancer.
Not every patient requires extensive molecular testing before surgery. However, in selected patients, molecular testing may help doctors make more informed treatment decisions.
Pre-operative molecular testing may help:
This is becoming an increasingly important part of modern precision oncology worldwide.
Some endometrial cancers may be linked to an inherited condition called Lynch syndrome.
Detecting this condition can help:
Because of this, many international oncology guidelines now recommend molecular evaluation in selected endometrial cancer patients.
Not necessarily.
Many patients believe robotic surgery is the only advanced treatment option.
One of the most important advancements in modern gynecologic oncology is the integration of precision-guided minimally invasive surgery with fluorescence-guided sentinel lymph node mapping, enabling more accurate cancer staging and treatment.
Advanced fluorescence-guided surgery using SPY-PHI technology and high-definition Stryker 1788 imaging is considered a modern and highly advanced approach in endometrial cancer treatment worldwide.
In appropriately chosen patients, minimally invasive surgical techniques for endometrial cancer can provide:
Cancer care is becoming more personalized than ever before.
Modern oncology is no longer only about where the cancer is located — it is also about understanding how the cancer behaves biologically.
The future of gynecologic oncology combines:
Collectively, these advancements are improving the effectiveness, accuracy, and safety of endometrial cancer management.
Is hysterectomy enough for endometrial cancer?
In many patients, hysterectomy is the primary treatment. However, doctors may also need to evaluate whether cancer has spread microscopically to nearby lymph nodes.
What is Sentinel Lymph Node Biopsy?
It is a technique used to identify the first lymph nodes where cancer is most likely to spread, helping improve staging accuracy while reducing unnecessary lymph node removal.
Is genetic testing necessary before endometrial cancer surgery?
Not always. However, molecular testing and NGS may help guide treatment planning in selected patients.
What is SPY-PHI technology?
SPY-PHI is an advanced fluorescence-guided imaging system used during minimally invasive surgery to help surgeons identify important lymphatic pathways and sentinel lymph nodes.
Is robotic surgery always better?
Robotic surgery is one advanced surgical platform. However, precision-guided minimally invasive surgery combined with fluorescence-guided sentinel node mapping is itself considered a highly advanced modern approach.
What are common symptoms of endometrial cancer?
Common symptoms may include:
Women experiencing these symptoms are advised to seek prompt medical evaluation for appropriate diagnosis and care.
Ravi’s American Cancer Care offers advanced precision oncology services including: